nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—ALB—breast cancer	0.212	1	CbGaD
Cefazolin—ABCC4—Fluorouracil—breast cancer	0.087	0.271	CbGbCtD
Cefazolin—SLC22A11—Methotrexate—breast cancer	0.0515	0.161	CbGbCtD
Cefazolin—ABCC4—Methotrexate—breast cancer	0.048	0.149	CbGbCtD
Cefazolin—ALB—Irinotecan—breast cancer	0.0336	0.105	CbGbCtD
Cefazolin—ALB—Fluorouracil—breast cancer	0.0323	0.1	CbGbCtD
Cefazolin—SLC22A8—Methotrexate—breast cancer	0.03	0.0934	CbGbCtD
Cefazolin—SLC22A6—Methotrexate—breast cancer	0.0209	0.0651	CbGbCtD
Cefazolin—ALB—Methotrexate—breast cancer	0.0178	0.0554	CbGbCtD
Cefazolin—PON1—bone marrow—breast cancer	0.00413	0.127	CbGeAlD
Cefazolin—PON1—endocrine gland—breast cancer	0.0037	0.114	CbGeAlD
Cefazolin—TPMT—nipple—breast cancer	0.00266	0.0818	CbGeAlD
Cefazolin—ALB—mammary gland—breast cancer	0.00199	0.0614	CbGeAlD
Cefazolin—TPMT—endometrium—breast cancer	0.0016	0.0494	CbGeAlD
Cefazolin—TPMT—pituitary gland—breast cancer	0.00145	0.0447	CbGeAlD
Cefazolin—TPMT—adipose tissue—breast cancer	0.00145	0.0445	CbGeAlD
Cefazolin—SLC22A11—female reproductive system—breast cancer	0.0014	0.0432	CbGeAlD
Cefazolin—TPMT—adrenal gland—breast cancer	0.0013	0.0399	CbGeAlD
Cefazolin—TPMT—bone marrow—breast cancer	0.00125	0.0386	CbGeAlD
Cefazolin—TPMT—female gonad—breast cancer	0.00121	0.0372	CbGeAlD
Cefazolin—SLC22A11—endocrine gland—breast cancer	0.00119	0.0366	CbGeAlD
Cefazolin—TPMT—endocrine gland—breast cancer	0.00112	0.0346	CbGeAlD
Cefazolin—ABCC4—uterus—breast cancer	0.000889	0.0274	CbGeAlD
Cefazolin—ABCC4—adipose tissue—breast cancer	0.000869	0.0268	CbGeAlD
Cefazolin—ALB—adrenal gland—breast cancer	0.000805	0.0248	CbGeAlD
Cefazolin—ABCC4—female reproductive system—breast cancer	0.000799	0.0246	CbGeAlD
Cefazolin—ABCC4—adrenal gland—breast cancer	0.00078	0.024	CbGeAlD
Cefazolin—TPMT—lymph node—breast cancer	0.000778	0.0239	CbGeAlD
Cefazolin—ABCC4—bone marrow—breast cancer	0.000754	0.0232	CbGeAlD
Cefazolin—ABCC4—female gonad—breast cancer	0.000727	0.0224	CbGeAlD
Cefazolin—ABCC4—endocrine gland—breast cancer	0.000676	0.0208	CbGeAlD
Cefazolin—ALB—lymph node—breast cancer	0.000483	0.0149	CbGeAlD
Cefazolin—ABCC4—lymph node—breast cancer	0.000467	0.0144	CbGeAlD
Cefazolin—Cefotetan—ALB—breast cancer	0.000366	0.171	CrCbGaD
Cefazolin—Cefpiramide—ALB—breast cancer	0.000318	0.149	CrCbGaD
Cefazolin—Cefonicid—ALB—breast cancer	0.000277	0.13	CrCbGaD
Cefazolin—Cefmetazole—ALB—breast cancer	0.000244	0.114	CrCbGaD
Cefazolin—Cefradine—CYP3A4—breast cancer	0.00018	0.0839	CrCbGaD
Cefazolin—Cefoperazone—ALB—breast cancer	0.000163	0.0764	CrCbGaD
Cefazolin—Pancytopenia—Epirubicin—breast cancer	0.000137	0.000465	CcSEcCtD
Cefazolin—Anorexia—Paclitaxel—breast cancer	0.000137	0.000464	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000137	0.000462	CcSEcCtD
Cefazolin—Vomiting—Vinorelbine—breast cancer	0.000136	0.00046	CcSEcCtD
Cefazolin—Body temperature increased—Gemcitabine—breast cancer	0.000136	0.00046	CcSEcCtD
Cefazolin—Renal failure—Methotrexate—breast cancer	0.000136	0.000458	CcSEcCtD
Cefazolin—Cephalexin—CYP2D6—breast cancer	0.000135	0.0633	CrCbGaD
Cefazolin—Neutropenia—Epirubicin—breast cancer	0.000135	0.000458	CcSEcCtD
Cefazolin—Dizziness—Thiotepa—breast cancer	0.000135	0.000457	CcSEcCtD
Cefazolin—Rash—Vinorelbine—breast cancer	0.000135	0.000456	CcSEcCtD
Cefazolin—Dermatitis—Vinorelbine—breast cancer	0.000135	0.000456	CcSEcCtD
Cefazolin—Hypotension—Paclitaxel—breast cancer	0.000135	0.000455	CcSEcCtD
Cefazolin—Stomatitis—Methotrexate—breast cancer	0.000134	0.000455	CcSEcCtD
Cefazolin—Urticaria—Fluorouracil—breast cancer	0.000134	0.000454	CcSEcCtD
Cefazolin—Headache—Vinorelbine—breast cancer	0.000134	0.000453	CcSEcCtD
Cefazolin—Syncope—Docetaxel—breast cancer	0.000134	0.000453	CcSEcCtD
Cefazolin—Leukopenia—Docetaxel—breast cancer	0.000134	0.000453	CcSEcCtD
Cefazolin—Anaemia—Capecitabine—breast cancer	0.000134	0.000452	CcSEcCtD
Cefazolin—Body temperature increased—Fluorouracil—breast cancer	0.000134	0.000452	CcSEcCtD
Cefazolin—Eosinophilia—Doxorubicin—breast cancer	0.000133	0.000448	CcSEcCtD
Cefazolin—Loss of consciousness—Docetaxel—breast cancer	0.000131	0.000444	CcSEcCtD
Cefazolin—Hypersensitivity—Mitoxantrone—breast cancer	0.00013	0.00044	CcSEcCtD
Cefazolin—Hypersensitivity—Irinotecan—breast cancer	0.00013	0.00044	CcSEcCtD
Cefazolin—Vomiting—Thiotepa—breast cancer	0.00013	0.00044	CcSEcCtD
Cefazolin—Syncope—Capecitabine—breast cancer	0.00013	0.000439	CcSEcCtD
Cefazolin—Leukopenia—Capecitabine—breast cancer	0.00013	0.000438	CcSEcCtD
Cefazolin—Convulsion—Docetaxel—breast cancer	0.00013	0.000438	CcSEcCtD
Cefazolin—Rash—Thiotepa—breast cancer	0.000129	0.000436	CcSEcCtD
Cefazolin—Dermatitis—Thiotepa—breast cancer	0.000129	0.000435	CcSEcCtD
Cefazolin—Agranulocytosis—Methotrexate—breast cancer	0.000129	0.000435	CcSEcCtD
Cefazolin—Headache—Thiotepa—breast cancer	0.000128	0.000433	CcSEcCtD
Cefazolin—Somnolence—Paclitaxel—breast cancer	0.000128	0.000433	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000128	0.000433	CcSEcCtD
Cefazolin—Ceftriaxone—ALB—breast cancer	0.000127	0.0595	CrCbGaD
Cefazolin—Loss of consciousness—Capecitabine—breast cancer	0.000127	0.00043	CcSEcCtD
Cefazolin—Pancytopenia—Doxorubicin—breast cancer	0.000127	0.00043	CcSEcCtD
Cefazolin—Nausea—Vinorelbine—breast cancer	0.000127	0.00043	CcSEcCtD
Cefazolin—Renal failure—Epirubicin—breast cancer	0.000127	0.000429	CcSEcCtD
Cefazolin—Dyspepsia—Paclitaxel—breast cancer	0.000127	0.000429	CcSEcCtD
Cefazolin—Asthenia—Mitoxantrone—breast cancer	0.000127	0.000428	CcSEcCtD
Cefazolin—Asthenia—Irinotecan—breast cancer	0.000127	0.000428	CcSEcCtD
Cefazolin—Stomatitis—Epirubicin—breast cancer	0.000126	0.000425	CcSEcCtD
Cefazolin—Neutropenia—Doxorubicin—breast cancer	0.000125	0.000423	CcSEcCtD
Cefazolin—Decreased appetite—Paclitaxel—breast cancer	0.000125	0.000423	CcSEcCtD
Cefazolin—Hypersensitivity—Fluorouracil—breast cancer	0.000125	0.000421	CcSEcCtD
Cefazolin—Haemoglobin—Methotrexate—breast cancer	0.000124	0.000421	CcSEcCtD
Cefazolin—Fatigue—Paclitaxel—breast cancer	0.000124	0.00042	CcSEcCtD
Cefazolin—Haemorrhage—Methotrexate—breast cancer	0.000124	0.000419	CcSEcCtD
Cefazolin—Hepatitis—Methotrexate—breast cancer	0.000124	0.000419	CcSEcCtD
Cefazolin—Asthenia—Gemcitabine—breast cancer	0.000123	0.000417	CcSEcCtD
Cefazolin—Pain—Paclitaxel—breast cancer	0.000123	0.000416	CcSEcCtD
Cefazolin—Confusional state—Docetaxel—breast cancer	0.000123	0.000416	CcSEcCtD
Cefazolin—Anaphylactic shock—Docetaxel—breast cancer	0.000122	0.000413	CcSEcCtD
Cefazolin—Pruritus—Gemcitabine—breast cancer	0.000122	0.000411	CcSEcCtD
Cefazolin—Nausea—Thiotepa—breast cancer	0.000121	0.000411	CcSEcCtD
Cefazolin—Diarrhoea—Mitoxantrone—breast cancer	0.000121	0.000408	CcSEcCtD
Cefazolin—Diarrhoea—Irinotecan—breast cancer	0.000121	0.000408	CcSEcCtD
Cefazolin—Agranulocytosis—Epirubicin—breast cancer	0.00012	0.000407	CcSEcCtD
Cefazolin—Shock—Docetaxel—breast cancer	0.00012	0.000406	CcSEcCtD
Cefazolin—Pruritus—Fluorouracil—breast cancer	0.00012	0.000405	CcSEcCtD
Cefazolin—Thrombocytopenia—Docetaxel—breast cancer	0.00012	0.000404	CcSEcCtD
Cefazolin—Confusional state—Capecitabine—breast cancer	0.000119	0.000403	CcSEcCtD
Cefazolin—Feeling abnormal—Paclitaxel—breast cancer	0.000119	0.000401	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000118	0.0004	CcSEcCtD
Cefazolin—Gastrointestinal pain—Paclitaxel—breast cancer	0.000118	0.000398	CcSEcCtD
Cefazolin—Diarrhoea—Gemcitabine—breast cancer	0.000118	0.000398	CcSEcCtD
Cefazolin—Renal failure—Doxorubicin—breast cancer	0.000117	0.000397	CcSEcCtD
Cefazolin—Erythema multiforme—Methotrexate—breast cancer	0.000117	0.000396	CcSEcCtD
Cefazolin—Dizziness—Irinotecan—breast cancer	0.000117	0.000395	CcSEcCtD
Cefazolin—Haemoglobin—Epirubicin—breast cancer	0.000116	0.000394	CcSEcCtD
Cefazolin—Stomatitis—Doxorubicin—breast cancer	0.000116	0.000394	CcSEcCtD
Cefazolin—Anorexia—Docetaxel—breast cancer	0.000116	0.000393	CcSEcCtD
Cefazolin—Shock—Capecitabine—breast cancer	0.000116	0.000393	CcSEcCtD
Cefazolin—Cephalexin—CYP3A4—breast cancer	0.000116	0.0543	CrCbGaD
Cefazolin—Hepatitis—Epirubicin—breast cancer	0.000116	0.000392	CcSEcCtD
Cefazolin—Haemorrhage—Epirubicin—breast cancer	0.000116	0.000392	CcSEcCtD
Cefazolin—Diarrhoea—Fluorouracil—breast cancer	0.000116	0.000391	CcSEcCtD
Cefazolin—Thrombocytopenia—Capecitabine—breast cancer	0.000116	0.000391	CcSEcCtD
Cefazolin—Urticaria—Paclitaxel—breast cancer	0.000114	0.000387	CcSEcCtD
Cefazolin—Hypotension—Docetaxel—breast cancer	0.000114	0.000386	CcSEcCtD
Cefazolin—Body temperature increased—Paclitaxel—breast cancer	0.000114	0.000385	CcSEcCtD
Cefazolin—Abdominal pain—Paclitaxel—breast cancer	0.000114	0.000385	CcSEcCtD
Cefazolin—Anorexia—Capecitabine—breast cancer	0.000113	0.000381	CcSEcCtD
Cefazolin—Vomiting—Mitoxantrone—breast cancer	0.000112	0.00038	CcSEcCtD
Cefazolin—Vomiting—Irinotecan—breast cancer	0.000112	0.00038	CcSEcCtD
Cefazolin—Dizziness—Fluorouracil—breast cancer	0.000112	0.000378	CcSEcCtD
Cefazolin—Cefalotin—ALB—breast cancer	0.000111	0.0521	CrCbGaD
Cefazolin—Agranulocytosis—Doxorubicin—breast cancer	0.000111	0.000377	CcSEcCtD
Cefazolin—Rash—Irinotecan—breast cancer	0.000111	0.000376	CcSEcCtD
Cefazolin—Rash—Mitoxantrone—breast cancer	0.000111	0.000376	CcSEcCtD
Cefazolin—Dermatitis—Irinotecan—breast cancer	0.000111	0.000376	CcSEcCtD
Cefazolin—Dermatitis—Mitoxantrone—breast cancer	0.000111	0.000376	CcSEcCtD
Cefazolin—Headache—Irinotecan—breast cancer	0.000111	0.000374	CcSEcCtD
Cefazolin—Headache—Mitoxantrone—breast cancer	0.000111	0.000374	CcSEcCtD
Cefazolin—Hypotension—Capecitabine—breast cancer	0.00011	0.000373	CcSEcCtD
Cefazolin—Erythema multiforme—Epirubicin—breast cancer	0.00011	0.00037	CcSEcCtD
Cefazolin—Vomiting—Gemcitabine—breast cancer	0.000109	0.00037	CcSEcCtD
Cefazolin—Somnolence—Docetaxel—breast cancer	0.000109	0.000367	CcSEcCtD
Cefazolin—Rash—Gemcitabine—breast cancer	0.000108	0.000367	CcSEcCtD
Cefazolin—Dermatitis—Gemcitabine—breast cancer	0.000108	0.000366	CcSEcCtD
Cefazolin—Haemoglobin—Doxorubicin—breast cancer	0.000108	0.000364	CcSEcCtD
Cefazolin—Headache—Gemcitabine—breast cancer	0.000108	0.000364	CcSEcCtD
Cefazolin—Vomiting—Fluorouracil—breast cancer	0.000108	0.000364	CcSEcCtD
Cefazolin—Dyspepsia—Docetaxel—breast cancer	0.000107	0.000363	CcSEcCtD
Cefazolin—Hepatitis—Doxorubicin—breast cancer	0.000107	0.000362	CcSEcCtD
Cefazolin—Haemorrhage—Doxorubicin—breast cancer	0.000107	0.000362	CcSEcCtD
Cefazolin—Rash—Fluorouracil—breast cancer	0.000107	0.00036	CcSEcCtD
Cefazolin—Dermatitis—Fluorouracil—breast cancer	0.000107	0.00036	CcSEcCtD
Cefazolin—Decreased appetite—Docetaxel—breast cancer	0.000106	0.000359	CcSEcCtD
Cefazolin—Hypersensitivity—Paclitaxel—breast cancer	0.000106	0.000359	CcSEcCtD
Cefazolin—Headache—Fluorouracil—breast cancer	0.000106	0.000358	CcSEcCtD
Cefazolin—Fatigue—Docetaxel—breast cancer	0.000105	0.000356	CcSEcCtD
Cefazolin—Nausea—Irinotecan—breast cancer	0.000105	0.000355	CcSEcCtD
Cefazolin—Nausea—Mitoxantrone—breast cancer	0.000105	0.000355	CcSEcCtD
Cefazolin—Pain—Docetaxel—breast cancer	0.000104	0.000353	CcSEcCtD
Cefazolin—Dyspepsia—Capecitabine—breast cancer	0.000104	0.000352	CcSEcCtD
Cefazolin—Asthenia—Paclitaxel—breast cancer	0.000103	0.000349	CcSEcCtD
Cefazolin—Decreased appetite—Capecitabine—breast cancer	0.000103	0.000347	CcSEcCtD
Cefazolin—Nausea—Gemcitabine—breast cancer	0.000102	0.000345	CcSEcCtD
Cefazolin—Fatigue—Capecitabine—breast cancer	0.000102	0.000344	CcSEcCtD
Cefazolin—Pruritus—Paclitaxel—breast cancer	0.000102	0.000344	CcSEcCtD
Cefazolin—Erythema multiforme—Doxorubicin—breast cancer	0.000101	0.000343	CcSEcCtD
Cefazolin—Cephalexin—ALB—breast cancer	0.000101	0.0474	CrCbGaD
Cefazolin—Pain—Capecitabine—breast cancer	0.000101	0.000342	CcSEcCtD
Cefazolin—Feeling abnormal—Docetaxel—breast cancer	0.000101	0.00034	CcSEcCtD
Cefazolin—Nausea—Fluorouracil—breast cancer	0.0001	0.00034	CcSEcCtD
Cefazolin—Gastrointestinal pain—Docetaxel—breast cancer	9.98e-05	0.000337	CcSEcCtD
Cefazolin—Anaemia—Methotrexate—breast cancer	9.96e-05	0.000337	CcSEcCtD
Cefazolin—Flatulence—Epirubicin—breast cancer	9.94e-05	0.000336	CcSEcCtD
Cefazolin—Diarrhoea—Paclitaxel—breast cancer	9.85e-05	0.000333	CcSEcCtD
Cefazolin—Feeling abnormal—Capecitabine—breast cancer	9.74e-05	0.000329	CcSEcCtD
Cefazolin—Gastrointestinal pain—Capecitabine—breast cancer	9.66e-05	0.000327	CcSEcCtD
Cefazolin—Abdominal pain—Docetaxel—breast cancer	9.65e-05	0.000326	CcSEcCtD
Cefazolin—Body temperature increased—Docetaxel—breast cancer	9.65e-05	0.000326	CcSEcCtD
Cefazolin—Leukopenia—Methotrexate—breast cancer	9.65e-05	0.000326	CcSEcCtD
Cefazolin—Dizziness—Paclitaxel—breast cancer	9.52e-05	0.000322	CcSEcCtD
Cefazolin—Urticaria—Capecitabine—breast cancer	9.39e-05	0.000317	CcSEcCtD
Cefazolin—Body temperature increased—Capecitabine—breast cancer	9.34e-05	0.000316	CcSEcCtD
Cefazolin—Abdominal pain—Capecitabine—breast cancer	9.34e-05	0.000316	CcSEcCtD
Cefazolin—Convulsion—Methotrexate—breast cancer	9.34e-05	0.000316	CcSEcCtD
Cefazolin—Anaemia—Epirubicin—breast cancer	9.32e-05	0.000315	CcSEcCtD
Cefazolin—Agitation—Epirubicin—breast cancer	9.27e-05	0.000313	CcSEcCtD
Cefazolin—Flatulence—Doxorubicin—breast cancer	9.2e-05	0.000311	CcSEcCtD
Cefazolin—Vomiting—Paclitaxel—breast cancer	9.16e-05	0.00031	CcSEcCtD
Cefazolin—Rash—Paclitaxel—breast cancer	9.08e-05	0.000307	CcSEcCtD
Cefazolin—Dermatitis—Paclitaxel—breast cancer	9.07e-05	0.000307	CcSEcCtD
Cefazolin—Syncope—Epirubicin—breast cancer	9.05e-05	0.000306	CcSEcCtD
Cefazolin—Leukopenia—Epirubicin—breast cancer	9.03e-05	0.000305	CcSEcCtD
Cefazolin—Headache—Paclitaxel—breast cancer	9.02e-05	0.000305	CcSEcCtD
Cefazolin—Hypersensitivity—Docetaxel—breast cancer	8.99e-05	0.000304	CcSEcCtD
Cefazolin—Confusional state—Methotrexate—breast cancer	8.87e-05	0.0003	CcSEcCtD
Cefazolin—Loss of consciousness—Epirubicin—breast cancer	8.87e-05	0.0003	CcSEcCtD
Cefazolin—Anaphylactic shock—Methotrexate—breast cancer	8.8e-05	0.000297	CcSEcCtD
Cefazolin—Asthenia—Docetaxel—breast cancer	8.76e-05	0.000296	CcSEcCtD
Cefazolin—Convulsion—Epirubicin—breast cancer	8.74e-05	0.000295	CcSEcCtD
Cefazolin—Hypersensitivity—Capecitabine—breast cancer	8.71e-05	0.000294	CcSEcCtD
Cefazolin—Pruritus—Docetaxel—breast cancer	8.64e-05	0.000292	CcSEcCtD
Cefazolin—Anaemia—Doxorubicin—breast cancer	8.63e-05	0.000292	CcSEcCtD
Cefazolin—Thrombocytopenia—Methotrexate—breast cancer	8.61e-05	0.000291	CcSEcCtD
Cefazolin—Agitation—Doxorubicin—breast cancer	8.58e-05	0.00029	CcSEcCtD
Cefazolin—Nausea—Paclitaxel—breast cancer	8.55e-05	0.000289	CcSEcCtD
Cefazolin—Asthenia—Capecitabine—breast cancer	8.48e-05	0.000287	CcSEcCtD
Cefazolin—Anorexia—Methotrexate—breast cancer	8.39e-05	0.000284	CcSEcCtD
Cefazolin—Syncope—Doxorubicin—breast cancer	8.37e-05	0.000283	CcSEcCtD
Cefazolin—Pruritus—Capecitabine—breast cancer	8.36e-05	0.000283	CcSEcCtD
Cefazolin—Leukopenia—Doxorubicin—breast cancer	8.35e-05	0.000282	CcSEcCtD
Cefazolin—Diarrhoea—Docetaxel—breast cancer	8.35e-05	0.000282	CcSEcCtD
Cefazolin—Confusional state—Epirubicin—breast cancer	8.3e-05	0.000281	CcSEcCtD
Cefazolin—Anaphylactic shock—Epirubicin—breast cancer	8.23e-05	0.000278	CcSEcCtD
Cefazolin—Hypotension—Methotrexate—breast cancer	8.22e-05	0.000278	CcSEcCtD
Cefazolin—Loss of consciousness—Doxorubicin—breast cancer	8.2e-05	0.000277	CcSEcCtD
Cefazolin—Shock—Epirubicin—breast cancer	8.1e-05	0.000274	CcSEcCtD
Cefazolin—Convulsion—Doxorubicin—breast cancer	8.09e-05	0.000273	CcSEcCtD
Cefazolin—Diarrhoea—Capecitabine—breast cancer	8.09e-05	0.000273	CcSEcCtD
Cefazolin—Dizziness—Docetaxel—breast cancer	8.07e-05	0.000273	CcSEcCtD
Cefazolin—Thrombocytopenia—Epirubicin—breast cancer	8.06e-05	0.000273	CcSEcCtD
Cefazolin—Anorexia—Epirubicin—breast cancer	7.85e-05	0.000265	CcSEcCtD
Cefazolin—Somnolence—Methotrexate—breast cancer	7.82e-05	0.000264	CcSEcCtD
Cefazolin—Dizziness—Capecitabine—breast cancer	7.81e-05	0.000264	CcSEcCtD
Cefazolin—Vomiting—Docetaxel—breast cancer	7.76e-05	0.000262	CcSEcCtD
Cefazolin—Dyspepsia—Methotrexate—breast cancer	7.74e-05	0.000262	CcSEcCtD
Cefazolin—Rash—Docetaxel—breast cancer	7.7e-05	0.00026	CcSEcCtD
Cefazolin—Hypotension—Epirubicin—breast cancer	7.69e-05	0.00026	CcSEcCtD
Cefazolin—Dermatitis—Docetaxel—breast cancer	7.69e-05	0.00026	CcSEcCtD
Cefazolin—Confusional state—Doxorubicin—breast cancer	7.68e-05	0.00026	CcSEcCtD
Cefazolin—Decreased appetite—Methotrexate—breast cancer	7.65e-05	0.000259	CcSEcCtD
Cefazolin—Headache—Docetaxel—breast cancer	7.65e-05	0.000259	CcSEcCtD
Cefazolin—Anaphylactic shock—Doxorubicin—breast cancer	7.62e-05	0.000258	CcSEcCtD
Cefazolin—Fatigue—Methotrexate—breast cancer	7.58e-05	0.000256	CcSEcCtD
Cefazolin—Pain—Methotrexate—breast cancer	7.52e-05	0.000254	CcSEcCtD
Cefazolin—Vomiting—Capecitabine—breast cancer	7.51e-05	0.000254	CcSEcCtD
Cefazolin—Shock—Doxorubicin—breast cancer	7.49e-05	0.000253	CcSEcCtD
Cefazolin—Thrombocytopenia—Doxorubicin—breast cancer	7.46e-05	0.000252	CcSEcCtD
Cefazolin—Rash—Capecitabine—breast cancer	7.45e-05	0.000252	CcSEcCtD
Cefazolin—Dermatitis—Capecitabine—breast cancer	7.44e-05	0.000252	CcSEcCtD
Cefazolin—Headache—Capecitabine—breast cancer	7.4e-05	0.00025	CcSEcCtD
Cefazolin—Somnolence—Epirubicin—breast cancer	7.32e-05	0.000247	CcSEcCtD
Cefazolin—Anorexia—Doxorubicin—breast cancer	7.26e-05	0.000245	CcSEcCtD
Cefazolin—Nausea—Docetaxel—breast cancer	7.25e-05	0.000245	CcSEcCtD
Cefazolin—Feeling abnormal—Methotrexate—breast cancer	7.25e-05	0.000245	CcSEcCtD
Cefazolin—Dyspepsia—Epirubicin—breast cancer	7.25e-05	0.000245	CcSEcCtD
Cefazolin—Gastrointestinal pain—Methotrexate—breast cancer	7.19e-05	0.000243	CcSEcCtD
Cefazolin—Decreased appetite—Epirubicin—breast cancer	7.16e-05	0.000242	CcSEcCtD
Cefazolin—Hypotension—Doxorubicin—breast cancer	7.12e-05	0.000241	CcSEcCtD
Cefazolin—Fatigue—Epirubicin—breast cancer	7.1e-05	0.00024	CcSEcCtD
Cefazolin—Pain—Epirubicin—breast cancer	7.04e-05	0.000238	CcSEcCtD
Cefazolin—Nausea—Capecitabine—breast cancer	7.02e-05	0.000237	CcSEcCtD
Cefazolin—Urticaria—Methotrexate—breast cancer	6.99e-05	0.000236	CcSEcCtD
Cefazolin—Body temperature increased—Methotrexate—breast cancer	6.95e-05	0.000235	CcSEcCtD
Cefazolin—Abdominal pain—Methotrexate—breast cancer	6.95e-05	0.000235	CcSEcCtD
Cefazolin—Feeling abnormal—Epirubicin—breast cancer	6.78e-05	0.000229	CcSEcCtD
Cefazolin—Somnolence—Doxorubicin—breast cancer	6.77e-05	0.000229	CcSEcCtD
Cefazolin—Gastrointestinal pain—Epirubicin—breast cancer	6.73e-05	0.000228	CcSEcCtD
Cefazolin—Dyspepsia—Doxorubicin—breast cancer	6.71e-05	0.000227	CcSEcCtD
Cefazolin—Decreased appetite—Doxorubicin—breast cancer	6.62e-05	0.000224	CcSEcCtD
Cefazolin—Fatigue—Doxorubicin—breast cancer	6.57e-05	0.000222	CcSEcCtD
Cefazolin—Urticaria—Epirubicin—breast cancer	6.54e-05	0.000221	CcSEcCtD
Cefazolin—Pain—Doxorubicin—breast cancer	6.51e-05	0.00022	CcSEcCtD
Cefazolin—Abdominal pain—Epirubicin—breast cancer	6.51e-05	0.00022	CcSEcCtD
Cefazolin—Body temperature increased—Epirubicin—breast cancer	6.51e-05	0.00022	CcSEcCtD
Cefazolin—Hypersensitivity—Methotrexate—breast cancer	6.48e-05	0.000219	CcSEcCtD
Cefazolin—Asthenia—Methotrexate—breast cancer	6.31e-05	0.000213	CcSEcCtD
Cefazolin—Feeling abnormal—Doxorubicin—breast cancer	6.28e-05	0.000212	CcSEcCtD
Cefazolin—Gastrointestinal pain—Doxorubicin—breast cancer	6.23e-05	0.000211	CcSEcCtD
Cefazolin—Pruritus—Methotrexate—breast cancer	6.22e-05	0.00021	CcSEcCtD
Cefazolin—Hypersensitivity—Epirubicin—breast cancer	6.07e-05	0.000205	CcSEcCtD
Cefazolin—Urticaria—Doxorubicin—breast cancer	6.05e-05	0.000205	CcSEcCtD
Cefazolin—Abdominal pain—Doxorubicin—breast cancer	6.02e-05	0.000204	CcSEcCtD
Cefazolin—Body temperature increased—Doxorubicin—breast cancer	6.02e-05	0.000204	CcSEcCtD
Cefazolin—Diarrhoea—Methotrexate—breast cancer	6.02e-05	0.000203	CcSEcCtD
Cefazolin—Asthenia—Epirubicin—breast cancer	5.91e-05	0.0002	CcSEcCtD
Cefazolin—Pruritus—Epirubicin—breast cancer	5.82e-05	0.000197	CcSEcCtD
Cefazolin—Dizziness—Methotrexate—breast cancer	5.82e-05	0.000197	CcSEcCtD
Cefazolin—Diarrhoea—Epirubicin—breast cancer	5.63e-05	0.00019	CcSEcCtD
Cefazolin—Hypersensitivity—Doxorubicin—breast cancer	5.61e-05	0.00019	CcSEcCtD
Cefazolin—Vomiting—Methotrexate—breast cancer	5.59e-05	0.000189	CcSEcCtD
Cefazolin—Rash—Methotrexate—breast cancer	5.55e-05	0.000188	CcSEcCtD
Cefazolin—Dermatitis—Methotrexate—breast cancer	5.54e-05	0.000187	CcSEcCtD
Cefazolin—Headache—Methotrexate—breast cancer	5.51e-05	0.000186	CcSEcCtD
Cefazolin—Asthenia—Doxorubicin—breast cancer	5.47e-05	0.000185	CcSEcCtD
Cefazolin—Dizziness—Epirubicin—breast cancer	5.44e-05	0.000184	CcSEcCtD
Cefazolin—Pruritus—Doxorubicin—breast cancer	5.39e-05	0.000182	CcSEcCtD
Cefazolin—Vomiting—Epirubicin—breast cancer	5.23e-05	0.000177	CcSEcCtD
Cefazolin—Nausea—Methotrexate—breast cancer	5.23e-05	0.000177	CcSEcCtD
Cefazolin—Diarrhoea—Doxorubicin—breast cancer	5.21e-05	0.000176	CcSEcCtD
Cefazolin—Rash—Epirubicin—breast cancer	5.19e-05	0.000175	CcSEcCtD
Cefazolin—Dermatitis—Epirubicin—breast cancer	5.19e-05	0.000175	CcSEcCtD
Cefazolin—Headache—Epirubicin—breast cancer	5.16e-05	0.000174	CcSEcCtD
Cefazolin—Dizziness—Doxorubicin—breast cancer	5.04e-05	0.00017	CcSEcCtD
Cefazolin—Nausea—Epirubicin—breast cancer	4.89e-05	0.000165	CcSEcCtD
Cefazolin—Vomiting—Doxorubicin—breast cancer	4.84e-05	0.000164	CcSEcCtD
Cefazolin—Rash—Doxorubicin—breast cancer	4.8e-05	0.000162	CcSEcCtD
Cefazolin—Dermatitis—Doxorubicin—breast cancer	4.8e-05	0.000162	CcSEcCtD
Cefazolin—Headache—Doxorubicin—breast cancer	4.77e-05	0.000161	CcSEcCtD
Cefazolin—Nausea—Doxorubicin—breast cancer	4.52e-05	0.000153	CcSEcCtD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ABCB1—breast cancer	3.88e-05	0.000285	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MTHFR—breast cancer	3.87e-05	0.000284	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SRC—breast cancer	3.85e-05	0.000282	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—VEGFA—breast cancer	3.82e-05	0.00028	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TNF—breast cancer	3.82e-05	0.00028	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—HGF—breast cancer	3.82e-05	0.00028	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PLA2G4A—breast cancer	3.82e-05	0.00028	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	3.81e-05	0.00028	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GPX2—breast cancer	3.8e-05	0.000279	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—breast cancer	3.79e-05	0.000278	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—CSF2—breast cancer	3.77e-05	0.000277	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GPX4—breast cancer	3.76e-05	0.000276	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—breast cancer	3.75e-05	0.000275	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MMP1—breast cancer	3.7e-05	0.000271	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CFL1—breast cancer	3.68e-05	0.00027	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—IDH1—breast cancer	3.67e-05	0.000269	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GRB7—breast cancer	3.64e-05	0.000267	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—breast cancer	3.64e-05	0.000267	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CDK2—breast cancer	3.63e-05	0.000266	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PLAU—breast cancer	3.63e-05	0.000266	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CAV1—breast cancer	3.57e-05	0.000262	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SYNJ2—breast cancer	3.56e-05	0.000261	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CAV1—breast cancer	3.54e-05	0.00026	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—MAPK3—breast cancer	3.54e-05	0.00026	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	3.52e-05	0.000258	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—TGFB1—breast cancer	3.51e-05	0.000257	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TUBB3—breast cancer	3.45e-05	0.000253	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ALDOA—breast cancer	3.44e-05	0.000252	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFC—breast cancer	3.44e-05	0.000252	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—breast cancer	3.44e-05	0.000252	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	3.38e-05	0.000248	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—FN1—breast cancer	3.37e-05	0.000248	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TP53—breast cancer	3.37e-05	0.000247	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—breast cancer	3.34e-05	0.000245	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS2—breast cancer	3.33e-05	0.000245	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ALB—breast cancer	3.32e-05	0.000243	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NDUFS3—breast cancer	3.31e-05	0.000243	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CG—breast cancer	3.25e-05	0.000239	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CG—breast cancer	3.23e-05	0.000237	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—EGF—breast cancer	3.19e-05	0.000234	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—MED12—breast cancer	3.18e-05	0.000233	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CHST9—breast cancer	3.11e-05	0.000228	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—breast cancer	3.08e-05	0.000226	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	3.04e-05	0.000223	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—TNF—breast cancer	3.03e-05	0.000223	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—RAF1—breast cancer	3e-05	0.00022	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—FN1—breast cancer	2.96e-05	0.000217	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	2.96e-05	0.000217	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IGF1—breast cancer	2.96e-05	0.000217	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT2—breast cancer	2.95e-05	0.000217	CbGpPWpGaD
Cefazolin—ALB—Metabolism—COX11—breast cancer	2.95e-05	0.000216	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	2.93e-05	0.000215	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	2.9e-05	0.000213	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TGFB2—breast cancer	2.89e-05	0.000212	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—THBS1—breast cancer	2.88e-05	0.000211	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC2A2—breast cancer	2.87e-05	0.000211	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CD—breast cancer	2.86e-05	0.00021	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GATA3—breast cancer	2.84e-05	0.000208	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CD—breast cancer	2.84e-05	0.000208	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CG—breast cancer	2.83e-05	0.000208	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALB—breast cancer	2.82e-05	0.000207	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—ACHE—breast cancer	2.81e-05	0.000206	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCG2—breast cancer	2.81e-05	0.000206	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINE1—breast cancer	2.81e-05	0.000206	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ALB—breast cancer	2.8e-05	0.000206	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—EGF—breast cancer	2.8e-05	0.000206	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NOS3—breast cancer	2.7e-05	0.000198	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CDA—breast cancer	2.7e-05	0.000198	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SHMT1—breast cancer	2.7e-05	0.000198	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS3—breast cancer	2.68e-05	0.000197	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	2.66e-05	0.000195	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	2.64e-05	0.000193	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLCO1B1—breast cancer	2.6e-05	0.00019	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC2A5—breast cancer	2.6e-05	0.00019	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IGF1—breast cancer	2.6e-05	0.00019	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT2—breast cancer	2.59e-05	0.00019	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IFNB1—breast cancer	2.55e-05	0.000187	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	2.54e-05	0.000186	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—RAF1—breast cancer	2.53e-05	0.000186	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	2.53e-05	0.000186	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APRT—breast cancer	2.51e-05	0.000184	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TFRC—breast cancer	2.51e-05	0.000184	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CD—breast cancer	2.49e-05	0.000183	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CB—breast cancer	2.49e-05	0.000183	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CB—breast cancer	2.47e-05	0.000182	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTGS2—breast cancer	2.47e-05	0.000181	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SERPINE1—breast cancer	2.46e-05	0.000181	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—FASN—breast cancer	2.46e-05	0.000181	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—BCHE—breast cancer	2.45e-05	0.00018	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—breast cancer	2.45e-05	0.00018	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ALB—breast cancer	2.43e-05	0.000178	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—NCOA2—breast cancer	2.41e-05	0.000177	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—AKT1—breast cancer	2.39e-05	0.000175	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ESRRA—breast cancer	2.36e-05	0.000173	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ANGPTL4—breast cancer	2.36e-05	0.000173	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLAUR—breast cancer	2.34e-05	0.000172	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC5A5—breast cancer	2.3e-05	0.000169	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLG—breast cancer	2.29e-05	0.000168	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	2.29e-05	0.000168	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IL2—breast cancer	2.27e-05	0.000167	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	2.24e-05	0.000164	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HADHB—breast cancer	2.23e-05	0.000164	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPI—breast cancer	2.23e-05	0.000164	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—RAF1—breast cancer	2.22e-05	0.000163	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.22e-05	0.000163	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—RAF1—breast cancer	2.19e-05	0.000161	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PDGFA—breast cancer	2.17e-05	0.000159	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CB—breast cancer	2.17e-05	0.000159	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTEN—breast cancer	2.15e-05	0.000158	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.14e-05	0.000157	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDH1A1—breast cancer	2.13e-05	0.000156	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDH7A1—breast cancer	2.13e-05	0.000156	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	2.11e-05	0.000155	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ITPR1—breast cancer	2.11e-05	0.000155	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.11e-05	0.000155	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ABL1—breast cancer	2.09e-05	0.000154	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UMPS—breast cancer	2.04e-05	0.00015	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PHGDH—breast cancer	2.04e-05	0.00015	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ADSL—breast cancer	2.04e-05	0.00015	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FHL2—breast cancer	2.04e-05	0.00015	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NME1—breast cancer	2.04e-05	0.00015	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—NCOA1—breast cancer	2.03e-05	0.000149	CbGpPWpGaD
Cefazolin—ALB—Metabolism—BRIP1—breast cancer	2e-05	0.000147	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HPSE—breast cancer	2e-05	0.000147	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LDHB—breast cancer	2e-05	0.000147	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IL2—breast cancer	1.99e-05	0.000146	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SRC—breast cancer	1.98e-05	0.000145	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—PLG—breast cancer	1.98e-05	0.000145	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HGF—breast cancer	1.97e-05	0.000144	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLA2G4A—breast cancer	1.97e-05	0.000144	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CSF2—breast cancer	1.95e-05	0.000143	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFA—breast cancer	1.93e-05	0.000142	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	1.91e-05	0.00014	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMMR—breast cancer	1.9e-05	0.000139	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCC1—breast cancer	1.9e-05	0.000139	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA3—breast cancer	1.9e-05	0.000139	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARGC1B—breast cancer	1.84e-05	0.000135	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—HMOX1—breast cancer	1.83e-05	0.000134	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MAPK3—breast cancer	1.83e-05	0.000134	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.79e-05	0.000131	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.79e-05	0.000131	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TGFB1—breast cancer	1.77e-05	0.00013	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCB1—breast cancer	1.75e-05	0.000129	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SRC—breast cancer	1.74e-05	0.000128	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA4—breast cancer	1.74e-05	0.000127	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CA9—breast cancer	1.74e-05	0.000127	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.72e-05	0.000126	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.7e-05	0.000125	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFA—breast cancer	1.7e-05	0.000124	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPX2—breast cancer	1.69e-05	0.000124	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA2—breast cancer	1.69e-05	0.000124	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MMP1—breast cancer	1.67e-05	0.000123	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPX4—breast cancer	1.67e-05	0.000123	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SULT1A1—breast cancer	1.67e-05	0.000123	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CDK2—breast cancer	1.64e-05	0.000121	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLAU—breast cancer	1.64e-05	0.000121	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—KRAS—breast cancer	1.64e-05	0.00012	CbGpPWpGaD
Cefazolin—ALB—Metabolism—IDH1—breast cancer	1.63e-05	0.00012	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA1—breast cancer	1.63e-05	0.00012	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NAT2—breast cancer	1.62e-05	0.000119	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CAV1—breast cancer	1.6e-05	0.000118	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—MAPK3—breast cancer	1.6e-05	0.000118	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—TGFB1—breast cancer	1.56e-05	0.000114	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FN1—breast cancer	1.53e-05	0.000112	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CA—breast cancer	1.52e-05	0.000111	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS2—breast cancer	1.51e-05	0.000111	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CA—breast cancer	1.51e-05	0.000111	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CG—breast cancer	1.46e-05	0.000107	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.46e-05	0.000107	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TP53—breast cancer	1.46e-05	0.000107	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—EGF—breast cancer	1.44e-05	0.000106	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MED12—breast cancer	1.42e-05	0.000104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—DPYD—breast cancer	1.42e-05	0.000104	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HRAS—breast cancer	1.4e-05	0.000102	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDOA—breast cancer	1.39e-05	0.000102	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOA3—breast cancer	1.35e-05	9.93e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC2A2—breast cancer	1.34e-05	9.86e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IGF1—breast cancer	1.34e-05	9.82e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT2—breast cancer	1.34e-05	9.81e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.33e-05	9.76e-05	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	1.32e-05	9.72e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CPT1A—breast cancer	1.32e-05	9.66e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTR—breast cancer	1.32e-05	9.66e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCG2—breast cancer	1.32e-05	9.66e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HPGDS—breast cancer	1.29e-05	9.48e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CD—breast cancer	1.28e-05	9.43e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HBA1—breast cancer	1.28e-05	9.42e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINE1—breast cancer	1.27e-05	9.32e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACHE—breast cancer	1.25e-05	9.19e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTT1—breast cancer	1.25e-05	9.19e-05	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKT1—breast cancer	1.24e-05	9.1e-05	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT1—breast cancer	1.23e-05	9.04e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS3—breast cancer	1.21e-05	8.9e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP17A1—breast cancer	1.19e-05	8.7e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS1—breast cancer	1.17e-05	8.61e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ENO1—breast cancer	1.17e-05	8.61e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.17e-05	8.58e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2D6—breast cancer	1.15e-05	8.45e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RAF1—breast cancer	1.15e-05	8.41e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOA2—breast cancer	1.13e-05	8.29e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CB—breast cancer	1.12e-05	8.22e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FASN—breast cancer	1.1e-05	8.04e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—BCHE—breast cancer	1.09e-05	8.01e-05	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	1.08e-05	7.94e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC5A5—breast cancer	1.08e-05	7.91e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC2A1—breast cancer	1.04e-05	7.64e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NQO1—breast cancer	1.04e-05	7.64e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IL2—breast cancer	1.03e-05	7.54e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.02e-05	7.48e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP3A4—breast cancer	1.01e-05	7.45e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.01e-05	7.41e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1B1—breast cancer	9.98e-06	7.32e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	9.93e-06	7.28e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSP90AA1—breast cancer	9.79e-06	7.18e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOA1—breast cancer	9.52e-06	6.99e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP19A1—breast cancer	9.38e-06	6.89e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—STK11—breast cancer	9.38e-06	6.89e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SRC—breast cancer	8.97e-06	6.58e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.81e-06	6.46e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFA—breast cancer	8.74e-06	6.41e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—COMT—breast cancer	8.72e-06	6.4e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTP1—breast cancer	8.68e-06	6.37e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMOX1—breast cancer	8.56e-06	6.28e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ITPR1—breast cancer	8.54e-06	6.27e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MAPK3—breast cancer	8.27e-06	6.07e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCB1—breast cancer	8.22e-06	6.03e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TYMS—breast cancer	8.07e-06	5.92e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TGFB1—breast cancer	8.02e-06	5.89e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTM1—breast cancer	7.98e-06	5.85e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOR1—breast cancer	7.98e-06	5.85e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PLA2G4A—breast cancer	7.98e-06	5.85e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPX1—breast cancer	7.64e-06	5.61e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1A1—breast cancer	7.56e-06	5.55e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ERCC2—breast cancer	7.5e-06	5.5e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—KRAS—breast cancer	7.43e-06	5.45e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTHFR—breast cancer	7.05e-06	5.17e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CA—breast cancer	6.82e-06	5.01e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TP53—breast cancer	6.6e-06	4.84e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CAV1—breast cancer	6.5e-06	4.77e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HRAS—breast cancer	6.31e-06	4.63e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.21e-06	4.56e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CG—breast cancer	5.92e-06	4.35e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT1—breast cancer	5.57e-06	4.09e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CD—breast cancer	5.21e-06	3.82e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NOS3—breast cancer	4.92e-06	3.61e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CB—breast cancer	4.54e-06	3.33e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS2—breast cancer	4.5e-06	3.3e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTEN—breast cancer	3.92e-06	2.88e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CA—breast cancer	2.77e-06	2.03e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKT1—breast cancer	2.26e-06	1.66e-05	CbGpPWpGaD
